Finance Ministry issues Taxation and other Laws (Relaxation of Certain Provisions) Ordinance, 2020 today

In order to give effect to the announcements made by the Union Finance Minister vide Press Release dated 24.03.2020, regarding several relief measures relating to statutory and regulatory compliance matters across sectors in view of COVID-19 outbreak, the govt has brought in an Ordinance on 31.03.

Go to Source
Author:




Ministry of Shipping issues direction to all Major Ports not to levy any penalties/charges/fees on any Port user for any delay caused due to COVID-19

In wake of outbreak of COVID-19 and same being declared as Pandemic, the Government of India has imposed a lockdown for a period of 21 days to contain COVID-19 Pandemic in the country. Ministry of Home Affairs has issued an addendum, specifically giving exceptions to the operations of Seaports for cargo movement and inter-state movement of Goods/cargo for inland and exports to ensure regular supply of goods in the country.

Go to Source
Author:




Telephone Conversation between PM and the President of the Republic of France

Prime Minister Shri Narendra Modi had a telephonic conversation today with His Excellency Emmanuel Macron, President of the Republic of France. 

Prime Minister expressed his condolences to H.E. President Macron for the loss of lives in the ongoing COVID-19 pandemic.

Go to Source
Author:




Foreign Trade Policy 2015-2020 extended for one year;

The Union Commerce and Industry Ministry today announced changes in the Foreign Trade Policy (FTP) of Government of India. The present Policy which came into force on 1st April, 2015, is for 5 years and has validity upto 31st March, 2020.

Go to Source
Author:




Revision of ceiling price of Scheduled formulations

In compliance of the provisions of Drugs (Price Control) Order 2013, NPPA has revised/ increased the ceiling price of 883 scheduled formulations.

The Authority in its meeting held on 31.03.2020 noted with satisfaction that the supply disruption of APIs caused by COVID-19 outbreak is returning to normalcy and no unusual price fluctuations in price of inputs for medicines, amid COVID-19 outbreak has been reported.

Go to Source
Author: